ITMI20020913A0 - Nuova forma cristallina del cefdinir - Google Patents

Nuova forma cristallina del cefdinir

Info

Publication number
ITMI20020913A0
ITMI20020913A0 IT2002MI000913A ITMI20020913A ITMI20020913A0 IT MI20020913 A0 ITMI20020913 A0 IT MI20020913A0 IT 2002MI000913 A IT2002MI000913 A IT 2002MI000913A IT MI20020913 A ITMI20020913 A IT MI20020913A IT MI20020913 A0 ITMI20020913 A0 IT MI20020913A0
Authority
IT
Italy
Prior art keywords
cefdinir
crystalline form
new crystalline
new
crystalline
Prior art date
Application number
IT2002MI000913A
Other languages
English (en)
Inventor
Bruno Sala
Antonio Manca
Riccardo Monguzzi
Original Assignee
Acs Dobfar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acs Dobfar Spa filed Critical Acs Dobfar Spa
Priority to IT2002MI000913A priority Critical patent/ITMI20020913A0/it
Publication of ITMI20020913A0 publication Critical patent/ITMI20020913A0/it
Priority to US10/405,648 priority patent/US20030204082A1/en
Priority to JP2003101096A priority patent/JP4573154B2/ja
Priority to CA2424501A priority patent/CA2424501C/en
Priority to KR1020030026682A priority patent/KR100827559B1/ko
Priority to US11/129,425 priority patent/US20050209451A1/en
Priority to JP2010093100A priority patent/JP2010184925A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002MI000913A 2002-04-29 2002-04-29 Nuova forma cristallina del cefdinir ITMI20020913A0 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT2002MI000913A ITMI20020913A0 (it) 2002-04-29 2002-04-29 Nuova forma cristallina del cefdinir
US10/405,648 US20030204082A1 (en) 2002-04-29 2003-04-03 Crystalline form of cefdinir
JP2003101096A JP4573154B2 (ja) 2002-04-29 2003-04-04 セフジニルの新規な結晶形
CA2424501A CA2424501C (en) 2002-04-29 2003-04-04 New crystalline form of cefdinir
KR1020030026682A KR100827559B1 (ko) 2002-04-29 2003-04-28 세프디니르의 새로운 결정형
US11/129,425 US20050209451A1 (en) 2002-04-29 2005-05-16 Crystalline form of cefdinir
JP2010093100A JP2010184925A (ja) 2002-04-29 2010-04-14 セフジニルの新規な結晶形

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000913A ITMI20020913A0 (it) 2002-04-29 2002-04-29 Nuova forma cristallina del cefdinir

Publications (1)

Publication Number Publication Date
ITMI20020913A0 true ITMI20020913A0 (it) 2002-04-29

Family

ID=11449804

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000913A ITMI20020913A0 (it) 2002-04-29 2002-04-29 Nuova forma cristallina del cefdinir

Country Status (5)

Country Link
US (2) US20030204082A1 (it)
JP (2) JP4573154B2 (it)
KR (1) KR100827559B1 (it)
CA (1) CA2424501C (it)
IT (1) ITMI20020913A0 (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
DE60336331D1 (de) * 2002-08-13 2011-04-21 Sandoz Ag Ein cefdinir-zwischenprodukt
CA2520083A1 (en) * 2003-03-24 2004-10-07 Acs Dobfar S.P.A. Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
JP2008526782A (ja) * 2005-10-31 2008-07-24 テバ ファーマシューティカル インダストリーズ リミティド セフジニルセシウム塩結晶
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
ITMI20071628A1 (it) 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
CN103497204B (zh) * 2013-10-10 2016-03-23 珠海金鸿药业股份有限公司 一种头孢地尼化合物，其分散片及制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
ZA836918B (en) * 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
ZA885709B (en) * 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
JPH0674276B2 (ja) * 1987-08-19 1994-09-21 藤沢薬品工業株式会社 ７−［２−（２−アミノチアゾール−４−イル）−２−ヒドロキシイミノアセトアミド−３−ビニル−３−セフェム−４−カルボン酸（シン異性体）の新規結晶
JP3948628B2 (ja) * 1995-12-27 2007-07-25 ハンミ ファーマシューティカル シーオー．，エルティーディー． セフディニルの製造方法
AT405283B (de) * 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
JP4192599B2 (ja) * 2000-12-04 2008-12-10 アステラス製薬株式会社 アミノチアゾール誘導体の無水物の製造方法
US6388070B1 (en) * 2001-01-05 2002-05-14 Orchid Chemicals & Pharmaceuticals Ltd. Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
JP2005516011A (ja) * 2001-12-13 2005-06-02 ランバクシー ラボラトリーズ リミテッド 結晶二水化セフニディールカリウム
MXPA04010627A (es) * 2002-04-26 2005-02-14 Ranbaxy Lab Ltd Proceso para la preparacion de cefdinir.
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
DE60336331D1 (de) * 2002-08-13 2011-04-21 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
AU2003276525A1 (en) * 2002-11-15 2004-06-15 Orchid Chemicals And Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
AU2002368505A1 (en) * 2002-12-26 2004-07-22 Lupin Limited Novel intermediates for synthesis of cephalosporins and process for preparation of such intermediates
CA2520083A1 (en) * 2003-03-24 2004-10-07 Acs Dobfar S.P.A. Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20060287289A1 (en) * 2004-03-16 2006-12-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060025399A1 (en) * 2004-03-16 2006-02-02 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050215781A1 (en) * 2004-03-17 2005-09-29 Orchid Chemicals & Pharmaceuticals Ltd. Novel polymorph of cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20060029674A1 (en) * 2004-04-09 2006-02-09 Sever Nancy E Stable amorphous Cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic

Also Published As

Publication number Publication date
JP2010184925A (ja) 2010-08-26
US20050209451A1 (en) 2005-09-22
CA2424501A1 (en) 2003-10-29
US20030204082A1 (en) 2003-10-30
JP4573154B2 (ja) 2010-11-04
JP2004035543A (ja) 2004-02-05
CA2424501C (en) 2010-06-01
KR20030085492A (ko) 2003-11-05
KR100827559B1 (ko) 2008-05-07

Similar Documents

Publication Publication Date Title
ITMI20020913A0 (it) Nuova forma cristallina del cefdinir
FI7526U1 (fi) Kiteinen bikalutamidi
CY2015015I1 (el) Παραγωγη τιακουμυκινης
FR14C0045I2 (fr) Nouveau derive de 2-pyridylethylbenzamide
BR0313322B1 (pt) escova de dentes
FI20021262A0 (fi) Sokerien kiteytys
PT1255754E (pt) Forma ii cristalina de linezolido
ATE369365T1 (de) Kristallines mikronisat des tiotropiumbromids
DK1571942T3 (da) Tandbörste
ATE364610T1 (de) Kristalline polymorphe form von irinotecan- hyrochlorid
DK1682542T3 (da) Nyt krystallinsk anhydrat med anticholinerg effekt
DE60327554D1 (de) Wasserfreies kristallines azidocytosin-hemisulfat-derivat
ITRM20020555A0 (it) Forma cristallina anidra di cloridrato di valaciclovir.
PT1280803E (pt) Forma cristalina ii da cabergolina
AU2003297594A8 (en) Crystalline form
FR2844892B1 (fr) Horloge de surveillance de microcontroleur
IL166592A0 (en) Novel crystalline forms of gatifloxacin
IL165115A0 (en) Novel crystalline forms of gatifloxacin
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
DK1667537T3 (da) Modermælkserstatning
ITMI20042437A1 (it) Forma cristallina di rabeprazolo sodico
DE602004030779D1 (de) Angehen des problems des schrittmachersyndroms
NO20032637D0 (no) Tannbörste
NO20030416D0 (no) Krystallinsk terapeutisk forbindelse
ITMI20030638A1 (it) Forma cristallina di cefdinir